Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ARS Pharmaceuticals is a leading U.S.-based biopharmaceutical company focused on innovative therapies for severe allergic reactions. The company specializes in the development of needle-free emergency medications for the treatment of anaphylaxis, utilizing advanced delivery systems to improve patient care.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ARS Pharmaceuticals is scheduled to report its next quarterly earnings on 11/17/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
ARS Pharmaceuticals last reported quarterly earnings on 8/13/2026 (Q2 2026). Earnings per share (EPS) came in at -0.63 USD.
ARS Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.